p30 DBC is a potential regulator of tumorigenesis.

Ja Eun Kim, Junjie Chen, Zhenkun Lou

Research output: Contribution to journalArticle

Abstract

Tumorigenesis is a multistep process controlled by a number of proteins involved in diverse pathways. Traditionally, proteins are either considered as oncogenes, which promote tumorigenesis or as tumor suppressors, which prevent tumorigenesis. However, recent studies revealed quite a few proteins that could function as oncogene as well as tumor suppressor. A new member of such proteins is p30 DBC (deleted in breast cancer 1, also called DBC1). p30 DBC is one of the proteins involved in tumorigenesis that does not clearly adhere to either descriptions. Several studies show that p30 DBC is involved in cell proliferation, apoptosis and histone modification, all processes important for regulating tumorigenesis. However, there are other conflicting results regarding how p30 DBC contributes to tumorigenesis. The most interesting aspect of this is that p30 DBC is a strong inhibitor of SIRT1 protein deacetylase, whose exact role in tumorigenesis is currently under debate. This review summarizes the current understandings on p30 DBC functions, with a focus on the proposed roles of p30 DBC in tumorigenesis.

Original languageEnglish (US)
Pages (from-to)2932-2935
Number of pages4
JournalCell cycle (Georgetown, Tex.)
Volume8
Issue number18
StatePublished - Sep 15 2009
Externally publishedYes

Fingerprint

Carcinogenesis
Proteins
Oncogenes
Histone Code
Neoplasms
Cell Proliferation
Apoptosis
Breast Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

p30 DBC is a potential regulator of tumorigenesis. / Kim, Ja Eun; Chen, Junjie; Lou, Zhenkun.

In: Cell cycle (Georgetown, Tex.), Vol. 8, No. 18, 15.09.2009, p. 2932-2935.

Research output: Contribution to journalArticle

Kim, JE, Chen, J & Lou, Z 2009, 'p30 DBC is a potential regulator of tumorigenesis.', Cell cycle (Georgetown, Tex.), vol. 8, no. 18, pp. 2932-2935.
Kim, Ja Eun ; Chen, Junjie ; Lou, Zhenkun. / p30 DBC is a potential regulator of tumorigenesis. In: Cell cycle (Georgetown, Tex.). 2009 ; Vol. 8, No. 18. pp. 2932-2935.
@article{c69ff115afe7492ea3fe28952908a7ed,
title = "p30 DBC is a potential regulator of tumorigenesis.",
abstract = "Tumorigenesis is a multistep process controlled by a number of proteins involved in diverse pathways. Traditionally, proteins are either considered as oncogenes, which promote tumorigenesis or as tumor suppressors, which prevent tumorigenesis. However, recent studies revealed quite a few proteins that could function as oncogene as well as tumor suppressor. A new member of such proteins is p30 DBC (deleted in breast cancer 1, also called DBC1). p30 DBC is one of the proteins involved in tumorigenesis that does not clearly adhere to either descriptions. Several studies show that p30 DBC is involved in cell proliferation, apoptosis and histone modification, all processes important for regulating tumorigenesis. However, there are other conflicting results regarding how p30 DBC contributes to tumorigenesis. The most interesting aspect of this is that p30 DBC is a strong inhibitor of SIRT1 protein deacetylase, whose exact role in tumorigenesis is currently under debate. This review summarizes the current understandings on p30 DBC functions, with a focus on the proposed roles of p30 DBC in tumorigenesis.",
author = "Kim, {Ja Eun} and Junjie Chen and Zhenkun Lou",
year = "2009",
month = "9",
day = "15",
language = "English (US)",
volume = "8",
pages = "2932--2935",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "18",

}

TY - JOUR

T1 - p30 DBC is a potential regulator of tumorigenesis.

AU - Kim, Ja Eun

AU - Chen, Junjie

AU - Lou, Zhenkun

PY - 2009/9/15

Y1 - 2009/9/15

N2 - Tumorigenesis is a multistep process controlled by a number of proteins involved in diverse pathways. Traditionally, proteins are either considered as oncogenes, which promote tumorigenesis or as tumor suppressors, which prevent tumorigenesis. However, recent studies revealed quite a few proteins that could function as oncogene as well as tumor suppressor. A new member of such proteins is p30 DBC (deleted in breast cancer 1, also called DBC1). p30 DBC is one of the proteins involved in tumorigenesis that does not clearly adhere to either descriptions. Several studies show that p30 DBC is involved in cell proliferation, apoptosis and histone modification, all processes important for regulating tumorigenesis. However, there are other conflicting results regarding how p30 DBC contributes to tumorigenesis. The most interesting aspect of this is that p30 DBC is a strong inhibitor of SIRT1 protein deacetylase, whose exact role in tumorigenesis is currently under debate. This review summarizes the current understandings on p30 DBC functions, with a focus on the proposed roles of p30 DBC in tumorigenesis.

AB - Tumorigenesis is a multistep process controlled by a number of proteins involved in diverse pathways. Traditionally, proteins are either considered as oncogenes, which promote tumorigenesis or as tumor suppressors, which prevent tumorigenesis. However, recent studies revealed quite a few proteins that could function as oncogene as well as tumor suppressor. A new member of such proteins is p30 DBC (deleted in breast cancer 1, also called DBC1). p30 DBC is one of the proteins involved in tumorigenesis that does not clearly adhere to either descriptions. Several studies show that p30 DBC is involved in cell proliferation, apoptosis and histone modification, all processes important for regulating tumorigenesis. However, there are other conflicting results regarding how p30 DBC contributes to tumorigenesis. The most interesting aspect of this is that p30 DBC is a strong inhibitor of SIRT1 protein deacetylase, whose exact role in tumorigenesis is currently under debate. This review summarizes the current understandings on p30 DBC functions, with a focus on the proposed roles of p30 DBC in tumorigenesis.

UR - http://www.scopus.com/inward/record.url?scp=70450106348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70450106348&partnerID=8YFLogxK

M3 - Article

C2 - 19657230

VL - 8

SP - 2932

EP - 2935

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 18

ER -